Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Jefferies Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,900	Closed	-$3.62M	–	2065
2023 Q4	$3.62M	Buy	8,900 +5,000	+128%	+$1.85M	0.02%	499
2023 Q3	$1.36M	Buy	3,900 +3,600	+1,200%	+$1.26M	0.01%	732
2023 Q2	$106K	Sell	300 -19,700	-99%	-$6.64M	﹤0.01%	1507
2023 Q1	$6.3M	Sell	20,000 -200	-1%	-$60K	0.05%	307
2022 Q4	$5.83M	Buy	+20,200	New	+$6.16M	0.04%	359

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jefferies Financial Group's VRTX Position: Q2 2026 in Review

Jefferies Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $291K and leaving 23,154 shares worth $11.5M. The position accounts for 0.08% of the portfolio, ranked #226.

Jefferies Financial Group first reported a position in VRTX in Q1 2016 and has held it in 16 quarters since. The position peaked at $28.3M in Q2 2024. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Jefferies Financial Group held 23,154 shares of Vertex Pharmaceuticals worth $11.5M as of Q2 2026.
Jefferies Financial Group sold 656 Vertex Pharmaceuticals shares in Q2 2026, an estimated $291K.
Vertex Pharmaceuticals made up 0.08% of Jefferies Financial Group's portfolio in Q2 2026, its #226 holding.
Jefferies Financial Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
Jefferies Financial Group's Vertex Pharmaceuticals position peaked at $28.3M in Q2 2024.
1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.